Comparison of 25mg Versus 5 mg Lenalidomide as Maintenance Therapy in Patients With Multiple Myeloma

NCT00891384 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

194

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Lenalidomide
DRUG: Lenalidomide

Sponsor

Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH